MarketingMedicalPolicy,Access,Value, andEvidenceConsultingData,Technology,and Media
murmuration of birds

company news

Avalere Health adds an experienced executive in policy, access, value, evidence with appointment of Tim Wright


Tim Wright joins Avalere Health as Global President of Policy, Access, Value, and Evidence, to drive innovative integrated solutions for clients across the world.

We are delighted to announce that Tim Wright, a highly experienced executive in policy, access, value and evidence has joined our team at Avalere Health as the new President of its global Policy, Access, Value, and Evidence capability. The announcement was made just before the Professional Society for Health Economics and Outcomes Research (ISPOR) Europe meeting in Copenhagen, Denmark, being held from November 12 to 15.

“Tim is an accomplished and respected leader who brings more than 30 years of global experience in pricing, reimbursement and market access consultancy,” said Amar Urhekar, Chief Operating Officer. “He has a wealth of knowledge and expertise in managing teams and succeeding in this complex environment. Tim will ensure we deliver our industry-leading solutions to clients as they engage with our community of experts.”

With Tim at the helm, our team will continue to increase its collaborative engagements with Avalere Health’s policy, market access, HEOR, and healthcare transformation colleagues in the U.S., closing the gap in executing market access strategies for global brand launches. When the agency rebranded in October, leading HEOR and market access consultancies, such as Policy Analysis Inc (PAI), Skysis and PRMA Consulting, retired their names to adopt the Avalere Health moniker to further emphasize the agency’s integrated service offerings. Together, the company’s experts deliver unrivaled global expertise from Europe to North America, Latin America and the Asia-Pacific region, with clients benefiting from connected solutions from pre-clinical to post-launch that span a range of services in Consulting; Medical; Policy, Access, Value, and Evidence; Marketing and Digital Experience Technology.

Tim’s experience draws from more than 1,000 global engagements and senior leadership roles at companies including Evidera, United BioSource Corporation and Total Healthcare Group. He also has 12 years of country, regional and global in-house expertise at leading biopharmaceutical companies, such as AstraZeneca, Janssen-Cilag U.K., Allergan and Astra.

“Everyone recognizes the policy and market access landscape is becoming more complex and challenging for our clients,” added Tim. “The ever-increasing pressure from payers, demand for real-world evidence data and scrutiny on pricing means our client partnerships need to be more meaningful, innovative and comprehensive. Our strategic expertise is bolstered by the ability to draw on our medical, marketing and consulting colleagues within the Avalere Health team. Together, we create the connection that make better health happen.”

Tim will be at ISPOR Europe meeting with clients and colleagues to emphasize how Avalere Health’s interdisciplinary team of strategists, scientists, analysts and technologists offer a 360-degree view of the landscape across the product lifecycle. These integrated services range from driving early asset investment strategies to assessing how legislative changes impact coverage and access and creating relevant experiences that evolve.

Meet Tim Wright at booth C3-065

Learn how hēR­o3 can accelerate and empower HEOR.

Learn more about hēR­o3

Booth C3-065 at ISPOR Europe: Optimizing decisions with on-demand HEOR analytics and expert insights

While at ISPOR Europe, Tim and the team from Avalere Health will demonstrate how its digital solution, hēR­o3 accelerates and empowers health economics and outcomes research (HEOR). hēR­o3 enables companies to leverage HEOR insights for early assets to make more data-driven decisions, optimizing clinical development programs and avoiding costly mistakes. The application combines recent advances in technology with the team’s in-house modeling expertise to rapidly deliver understandable HEOR insights in hours or days, ensuring HEOR teams can now contribute critical insights into decision-making when they are called upon.

“hēRo3 transforms how global companies make informed decisions from the start of the drug development process and we’re excited to share it with ISPOR Europe attendees,” noted Tim.

  • Tim will be at the booth throughout Monday and Tuesday
  • The hēRo3 demonstration will occur every day throughout the day.

How we use cookies

Cookies are files saved on your phone, tablet or computer when you visit a website.

We use cookies to store information about how you use the Fishawack Health website, such as the pages you visit.

For more information, check the cookie statement


Cookie settings

We use 4 types of cookies. You can choose which cookies you're happy for us to use.

Cookies that measure website use.

We use Google Analytics to measure how you use the website so we can improve it based on user needs. We do not allow Google to use or share the data about how you use this site.

  • how you got to the site
  • the pages you visit on, and how long you spend on each page
  • what you click on while you're visiting the site

Cookies that help with our communications and marketing

These cookies may be set by third party websites and do things like measure how you view Vimeo videos that are on

Cookies that remember your settings

These cookies do things like remember your preferences and the choices you make, to personalize your experience of using the site.

Strictly necessary cookies

These essential cookies do things like remember your progress through a form (eg. Registering for new content alerts).

These cookies always need to be on.